Average Co-Inventor Count = 10.60
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (11 from 1,141 patents)
2. Smithkline Beecham Corporation (2 from 2,198 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (1 from 245 patents)
4. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)
5. Glaxo Inc. (1 from 56 patents)
16 patents:
1. 12331057 - Modulators of alpha-1 antitrypsin
2. 12281057 - Carboxamides as modulators of sodium channels
3. 12258333 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
4. 12247021 - Substituted tetrahydrofurans as modulators of sodium channels
5. 11919887 - Substituted tetrahydrofurans as modulators of sodium channels
6. 11884672 - Modulators of alpha-1 antitrypsin
7. 11834441 - Substituted tetrahydrofurans as modulators of sodium channels
8. 11827627 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
9. 11623924 - Modulators of alpha-1 antitrypsin
10. 11603351 - Carboxamides as modulators of sodium channels
11. 11053234 - 1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors
12. 10647661 - Carboxamides as modulators of sodium channels
13. 7625909 - Substituted quinazolinone compounds
14. 6649366 - Methods and compositions related to modulators of annexin and cartilage homeostasis
15. 6589934 - Kv2.1 antagonists